Who are the key players in North America Digital Diabetes Management Market industry?

The key players include Medtronic, Dexcom, Abbott Laboratories, Roche, and Tandem Diabetes Care. Medtronic leads with advanced insulin pump technology, while Dexcom specializes in continuous glucose monitoring (CGM) systems. Abbott Laboratories offers the popular FreeStyle Libre, Roche delivers integrated diabetes management solutions, and Tandem is known for its user-friendly t:slim X2 insulin pump.

Which segment accounted for the largest North America Digital Diabetes Management Market share?

Continuous glucose monitoring (CGM) applications held the largest market share, as users increasingly prefer real-time blood glucose data for better disease management. Companies like Abbott (FreeStyle Libre) and Dexcom have propelled this segment by offering easy-to-use, reliable wearables that support improved patient outcomes and proactive diabetes care.

What are the factors driving the North America Digital Diabetes Management Market?

Key drivers include growing diabetes incidence, government initiatives for chronic disease management, and rapid adoption of advanced wearables. For instance, Medtronic's launch of integrated hybrid closed-loop systems enables superior glucose control, responding to the demand for smart, automated diabetes management technologies.

Which type accounted for the largest North America Digital Diabetes Management Market share?

Wearable devices captured the largest market share, thanks to innovations in CGM sensors and smart insulin pumps. Products like the Dexcom G7 and Medtronic MiniMed offer ease of use and advanced analytics, enabling real-time monitoring and seamless integration with mobile apps, improving patient compliance and engagement.

Home Healthcare

North America Digital Diabetes Management Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

Q: What is the North America Digital Diabetes Management Market growth?

The North America Digital Diabetes Management Market is witnessing robust growth, driven by rising diabetes prevalence and technological advancements. For example, Dexcom reported significant revenue growth in 2023 owing to strong adoption of its G7 CGM system, reflecting increased demand for digital diabetes solutions across the region.

North America Digital Diabetes Management Market: by Type (Device, Application/App, Service, Data Management Software, Wearable, Others), Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes, Prediabetes, Others), Distribution Channels (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy, Clinics, Direct Tenders, Others), Technology (Smart Glucose Monitoring System, Continuous Blood Glucose Monitoring System, Insulin Delivery Technology, Artificial Intelligence, Internet of Things (IoT), Others), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025

Last Updated: 31-07-2025 | Format: PDF | Report ID:20458

Market Segmentation

Metrics	Details
Years	2020-2035
Base Year	2025
Market Size	5200
Regions	US, Canada, Mexico
Segments	Device, Application/App, Service, Data Management Software, Wearable, Others, Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes, Prediabetes, Retail Pharmacy, Hospital Pharmacy, Online Pharmacy, Clinics, Direct Tenders, Smart Glucose Monitoring System, Continuous Blood Glucose Monitoring System, Insulin Delivery Technology, Artificial Intelligence, Internet of Things (IoT), Small, Medium, Large
Players	Medtronic, Abbott Laboratories, Dexcom, F. Hoffmann-La Roche AG, Ascensia Diabetes Care, Tandem Diabetes Care, Insulet Corporation, Glooko, One Drop, Ypsomed Holding AG, AgaMatrix, LifeScan, DarioHealth, GlucoMe

Frequently asked questions

Key Questions Answered

»What is the market size and growth rate of the global and regional market by various segments?
»What is the market size and growth rate of the market for selective countries?
»Which region or sub-segment is expected to drive the market in the forecast period?
»What factors are estimated to drive and restrain the market growth?
»What are the key technological and market trends shaping the market?
»What are the key opportunities in the market?
»What are the key companies operating in the market?
»Which company accounted for the highest market share?

Why Choose Bussiness Insights?

»Strong Industry Focus
»Extensive Product Offerings
»Customer Research Services
»Robust Research Methodology
»Comprehensive Reports
»Latest Technological Developments
»Value Chain Analysis
»Potential Market Opportunities
»Growth Dynamics
»Quality Assurance
»Post-sales Support
»Regular Report Updates

Study period:

2020-2035

Base year:

2026

Historical data

2020-2024

NO OF PAGE:

167

Customize This Report to Suit Your Requirements

Name

Bussiness Email

country

Phone number

Consulting Service

How Will You Befit From our consulting service

Get in touch with Us

US +91 89837 31618 (Tool Free)

sales [at] bussinessinsights.com

Market Segmentation

Metrics	Details
Years	2020-2035
Base Year	2025
Market Size	5200
Regions	US, Canada, Mexico
Segments	Device, Application/App, Service, Data Management Software, Wearable, Others, Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes, Prediabetes, Retail Pharmacy, Hospital Pharmacy, Online Pharmacy, Clinics, Direct Tenders, Smart Glucose Monitoring System, Continuous Blood Glucose Monitoring System, Insulin Delivery Technology, Artificial Intelligence, Internet of Things (IoT), Small, Medium, Large
Players	Medtronic, Abbott Laboratories, Dexcom, F. Hoffmann-La Roche AG, Ascensia Diabetes Care, Tandem Diabetes Care, Insulet Corporation, Glooko, One Drop, Ypsomed Holding AG, AgaMatrix, LifeScan, DarioHealth, GlucoMe